Insufficient funds

Our Campaign to Save Compounded Hormones is running out of money.

I did not ever expect that to be news I’d need to deliver to you as your APC Board Chair, but here we are.

For whatever reason, many compounders who invested previously in this effort did not invest in the past 12 months, putting at risk our ability to push back against FDA’s implicit threat to restrict compounded hormones. Which is kinda weird, because the threat persists.

Maybe, because FDA has not moved ahead with restrictions in the three years since the manipulated NASEM report on compounded hormones landed with a thud, we’ve been lulled into thinking the threat is not real or that it’s gone away. But it hasn’t gone away. I would argue that our campaign, fueled by your investments over the past three years and the pressure that has been put on FDA, is the reason the threat has not yet materialized. But if we stop now, that pressure on FDA ceases, and all bets are off.

Without an infusion of support from folks like you, we will have exhausted all hormone campaign funds by March 31. Without additional funding:

• Efforts to engage patients in alerting their members of Congress about the threat will cease, and with it any push-back against FDA by members of Congress.
• Work to inform and engage prescribers in confronting the threat to essential compounded hormone therapies — they have a vested interest in supporting our efforts, of course — will end.
• Plans to subsidize the gathering of patient-reported outcomes data on compounded hormones by our member pharmacies will be scrapped – and with that, any hope of presenting compelling evidence to FDA demonstrating that compounded hormones do for patients what they purport to do.
• Plans to expand compounding.com — our campaign landing page that has attracted hundreds of thousands of page views and nearly 6,000 testimonials — into an “all things compounding” site for consumers will not be implemented.

In a survey two years ago, 77% of compounding pharmacy owners said compounded hormones were one of their top five business lines. If FDA succeeds in implementing restrictions, that business revenue goes away. More importantly, those patients you serve will be left with few alternatives.

We’ve got about six weeks to turn this around, so I’m asking for your help — NOW, not later. In fact, this is so urgent that I myself am investing $2,500 today.

INVEST HERE to Save Compounded Hormones

Please invest now — for the sake of your patients and business.

–  Joe

Joseph P. Navarra, RPh, FACA, FAPC is the owner of Town Total Compounding Center in Woodbury, New York. You can reach him at joseph.navarra@towntotalcompound.com.